Answers are grounded in this paper and cite their sources.
Tissue engineering approaches to repair or regenerate tissue or organ function has begun to reach clinical utility. Advances will depend on the optimization of critical constituents including the delivery scaffold, the participating cells, and the regulation of bioactive factors. This review provides a discussion of work published within the past year that was dedicated to studying one or more attributes of tissue engineering methods applicable to musculoskeletal tissues. The most substantial work has been directed at the development of technologies to control the three-dimensional architecture and chemistry of delivery matrices. The use of composites has continued to show particular promise. In addition, advances in the delivery of gene products to a repair site have begun to demonstrate potential for regulation and augmentation of the healing cascade.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: